Literature DB >> 19655282

Coronary computerized tomography angiography for rapid discharge of low-risk patients with cocaine-associated chest pain.

Kristy Walsh1, Anna Marie Chang, Jeanmarie Perrone, Christine McCusker, Frances Shofer, Mark Collin, Harold Litt, Judd Hollander.   

Abstract

BACKGROUND: Most patients presenting to emergency departments (EDs) with cocaine-associated chest pain are admitted for at least 12 hours and receive a "rule out acute coronary syndrome" protocol, often with noninvasive testing prior to discharge. In patients without cocaine use, coronary computerized tomography angiography (CTA) has been shown to be useful for identifying a group of patients at low risk for cardiac events who can be safely discharged. It is unclear whether a coronary CTA strategy would be efficacious in cocaine-associated chest pain, as coronary vasospasm may account for some of the ischemia. We studied whether a negative coronary CTA in patients with cocaine-associated chest pain could identify a subset safe for discharge.
METHODS: We prospectively evaluated the safety of coronary CTA for low-risk patients who presented to the ED with cocaineassociated chest pain (self-reported or positive urine test). Consecutive patients received either immediate coronary CTA in the ED (without serial markers) or underwent coronary CTA after a brief observation period with serial cardiac marker measurements. Patients with negative coronary CTA (maximal stenosis less than 50%) were discharged. The main outcome was 30-day cardiovascular death or myocardial infarction.
RESULTS: A total of 59 patients with cocaine-associated chest pain were evaluated. Patients had a mean age of 45.6 +/- 6.6 yrs and were 86% black, 66% male. Seventy-nine percent had a normal or nonspecific ECG and 85% had a TIMI score <2. Twenty patients received coronary CTA immediately in the ED, 18 of whom were discharged following CTA (90%). Thirty-nine received coronary CTA after a brief observation period, with 37 discharged home following CTA (95%). Six patients had coronary stenosis >or=50%. During the 30-day follow-up period, no patients died of a cardiovascular event (0%; 95% CI, 0-6.1%) and no patient sustained a nonfatal myocardial infarction (0%; 95% CI, 0-6.1%).
CONCLUSIONS: Although cocaine-associated myocardial ischemia can result from coronary vasoconstriction, patients with cocaine associated chest pain, a non-ischemic ECG, and a TIMI risk score <2 may be safely discharged from the ED after a negative coronary CTA with a low risk of 30-day adverse events.

Entities:  

Mesh:

Year:  2009        PMID: 19655282      PMCID: PMC3550393          DOI: 10.1007/bf03161220

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  54 in total

Review 1.  Stress testing in patients with cocaine-associated chest pain.

Authors:  Laszlo Littmann; Richard F Miller; Michael H Monroe
Journal:  J Emerg Med       Date:  2004-11       Impact factor: 1.484

2.  Emergency department presentation of cocaine intoxication.

Authors:  R W Derlet; T E Albertson
Journal:  Ann Emerg Med       Date:  1989-02       Impact factor: 5.721

Review 3.  Drug-induced pulmonary vascular disease--mechanisms and clinical patterns.

Authors:  K Kumar; W E Holden
Journal:  West J Med       Date:  1986-09

4.  Acute cardiac events temporally related to cocaine abuse.

Authors:  J M Isner; N A Estes; P D Thompson; M R Costanzo-Nordin; R Subramanian; G Miller; G Katsas; K Sweeney; W Q Sturner
Journal:  N Engl J Med       Date:  1986-12-04       Impact factor: 91.245

5.  Quantitative comparison of coronary artery flow and myocardial perfusion in patients with acute myocardial infarction in the presence and absence of recent cocaine use.

Authors:  Jim Edward Weber; Judd E Hollander; Sabina A Murphy; Eugene Braunwald; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

6.  Actual financial comparison of four strategies to evaluate patients with potential acute coronary syndromes.

Authors:  Anna Marie Chang; Frances S Shofer; Mark G Weiner; Marie B Synnestvedt; Harold I Litt; William G Baxt; Judd E Hollander
Journal:  Acad Emerg Med       Date:  2008-07       Impact factor: 3.451

7.  Cocaine and sudden "natural" death.

Authors:  R E Mittleman; C V Wetli
Journal:  J Forensic Sci       Date:  1987-01       Impact factor: 1.832

Review 8.  CT of coronary artery disease.

Authors:  U Joseph Schoepf; Christoph R Becker; Bernd M Ohnesorge; E Kent Yucel
Journal:  Radiology       Date:  2004-07       Impact factor: 11.105

9.  Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment.

Authors:  G Togna; E Tempesta; A R Togna; N Dolci; B Cebo; L Caprino
Journal:  Haemostasis       Date:  1985

10.  Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings.

Authors:  E N Arnett; J M Isner; D R Redwood; K M Kent; W P Baker; H Ackerstein; W C Roberts
Journal:  Ann Intern Med       Date:  1979-09       Impact factor: 25.391

View more
  3 in total

1.  Assessment of myocardial infarction by CT angiography and cardiovascular MRI in patients with cocaine-associated chest pain: a pilot study.

Authors:  K Paraschin; A Guerra De Andrade; J Rodrigues Parga
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

Review 2.  Rethinking cocaine-associated chest pain and acute coronary syndromes.

Authors:  Jonathan B Finkel; Gregary D Marhefka
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

3.  Self-reported cocaine use, emergency physician testing and outcomes in suspected acute coronary syndromes: a nested matched case-control study.

Authors:  Yang Wang; Christopher J Lindsell; Charles V Pollack; Judd Hollander; Deborah B Diercks; J Douglas Kirk; Venkataraman Anantharaman; W Brian Gibler; James Hoekstra; W Frank Peacock
Journal:  BMJ Open       Date:  2012-06-02       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.